Noxon
Partnered: 2023
Geography: Israel
Vertical: Life Sciences
www.noxon.com Oral drug for idiopathic pulmonary fibrosis (IPF) using 3-CP, a nitroxide compound known to protect against oxidative damage—slowing disease progression.
Backed by NGT Healthcare II.